You are here

EASD Rising Star Symposium & EFSD Research Fellowship

Supported by Novo Nordisk


Georgia Colleluori: Marche Polytechnic University - Ancona, Italy
Unravelling the role of the endogenous ciliary neurotrophic factor in the regulation of glucose homeostasis

Cintia Folgueira-Cobos: Spanish National Center for Cardiovascular Research Carlos III (CNIC) - Madrid, Spain
Unravelling the central role of p38α and its implications in metabolic disorders

Sini Marjut Heinonen: Helsinki University Hospital - Finland
Novel targets to activate adipose tissue metabolism for the treatment of obesity

Borja Martinez-Tellez: Torrecardenas University Hospital - Almeria, Spain
Revelling a new brown fat depot in young women with type 2 diabetes


Luca D'Onofrio: “Sapienza” University of Rome - Italy
Langerhans cells evaluated with corneal confocal microscopy and inflammation in autoimmune diabetes

Alessandro Mengozzi: University of Zuerich - Switzerland
Long non-coding RNAs as direct modulators of beta cell function: a translational study

Theresia Sarabhai: German Diabetes Center - Duesseldorf, Germany
Identifying early pathogenesis of overnutrion-mediated adipose tissue insulin resistance in healthy humans

Larke Smidt Gasbjerg: University of Copenhagen - Denmark
Imaging of gastrointestinal absorption, glucose distribution and metabolism using Total Body PET


Diego Balboa: Centre for Genomic Regulation - Barcelona, Spain
Regulatory landscape controlling human beta cell functional maturation

John Dennis: University of Exeter - UK
Individual-level cardiovascular and heart failure risk stratification to inform precision SGLT2-inhibitor treatment

Matthew Johnson: University of Exeter - UK
Identifying novel genetic causes of diabetes to give insights into mechanisms of beta cell autoimmunity

Salwan Maqdasy: Karolinska Institute - Huddinge, Sweden
Perturbed glutamine turnover drives adipocyte dysfunction and insulin resistance in obesity


Roksana Pirzgalska: Champalimaud Foundation - Lisbon, Portugal
A neuroepithelial circuit responsible for intestinal metabolism

Ilke Sen: Karolinska Institute - Stockholm, Sweden
Role of miRNAs in the regulation of skeletal muscle metabolism, growth and insulin sensitivity

Ben Stocks: University of Copenhagen - Denmark
Ubiquitin-proteasome dysfunction in the pathogenesis of type 2 diabetes

Oana Patricia Zaharia: German Diabetes Center -  Düsseldorf, Germany
Refining novel diabetes classifications by using markers of adipogenesis and adipose tissue distribution


Beatriz Merino Antolin: University of Valladolid - Spain
Discovering new targets in endocrine pancreas development: implications of insulin-degrading enzyme

Lucile Dollet: Karolinska Institutet - Solna, Sweden
Time-targeted exercise to fight type 2 diabetes: investigating the role of adipose tissue

Pierre Larraufie: AgroParisTech - Paris, France
Energy metabolism of enteroendocrine cells

Alexandra Smink: University Medical Center Groningen - Netherlands
Mimicking the pancreas microenvironment and prevent rejection within islet transplantation device


Shafqat Ahmad: Department of Medical Sciences, Uppsala University - Sweden
Molecular signatures of meat intake and risk of type 2 diabetes

Irene Miguel-Escalada: Bioinformatics and Genomics, CRG Barcelona - Spain
Molecular dissection of a new genome regulatory programme that underlies beta cell formation

Ivana Nikolic: CNIC, Madrid - Spain
T-cells and stress - novel regulators of obesity development

Domenico Trico: Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa - Italy
Post-prandial hypoglycaemia after RYGB in type 2 diabetes: impact on cognitive and cardiac function


Mariëtte Boon: Leiden University Medical Center - The Netherlands
Towards a new gold standard to quantify brown fat activity in humans

Elisa De Franco: University of Exeter Medical School - UK
Investigating development and function of human beta cells by gene discovery in neonatal diabetes

Nico De Leu: Vrije Universiteit Brussels - Belgium
mRNA therapy for experimental beta(-like) cell transplantation

Nikhil Gandasi: Uppsala University - Sweden
Are the mechanisms underlying secretion of islet hormones affected in type 2 diabetes?


Gustaf Christoffersson: Uppsala University - Sweden
Harnessing the immunosuppressive effects of the non-autoreactive islet infiltrate in type 1 diabetes

Teresa Mezza: Catholic University of the Sacred Heart - Rome, Italy
Investigating the role of intra-islet GLP-1 production in the modulation of islet plasticity in humans

Andrew Wood: University of Exeter - UK
Using genetics to understand the interaction between BMI and physical activity and risk of obesity and type 2 diabetes

Hanieh Yaghootkar: University of Exeter - UK
Using human genetics to understand the underlying mechanisms that protect some obese people from type 2 diabetes


Francesca D'Addio: San Raffaele Scientific Institute - Milan, Italy
Overriding the regulatory beta cell defect in type 1 diabetes 

Angus Jones: University of Exeter - UK
Using a genetic risk score to identify patients with type 1 diabetes who will require early insulin therapy

Sander Kooijman: Leiden University - The Netherlands
Time to heat up: targeting circadian rhythms in brown fat to combat diabetes

Niina Sandholm: Folkhälsan Research Center - Helsinki, Finland
Dissection of genetic background of diabetic nephropathy in subjects with type 1 diabetes


Martin Heni: University Hospital Tübingen - Germany
Effect of brain insulin action on pancreatic insulin secretion in humans

David Hodson: Imperial College London - UK
Optical control of beta cell function using a GLP-1R photoswitch

Ruben Nogueiras: University of Santiago de Compostela - Spain
Role of p53 on hepatic steatosis and insulin sensitivity

Robert Scott: University of Cambridge - UK
Novel insights into the role of adipogenesis in the aetiology of insulin resistance: a multidisciplinary approach


Gijs H Goossens: Maastricht University - The Netherlands
Targeting adipose tissue oxygen tension to improve insulin sensitivity in humans

Hiddo Jan Lambers Heerspink: Uni Medical Center - Groningen, The Netherlands
A new approach for personalised medicine in type 2 diabetes: integrating multiple effects of a single drug

Lorenzo Pasquali: FCRB - Barcelona, Spain
Identification of type 2 diabetes target genes

Rinke Stienstra: Radboud University - Nijmegen, The Netherlands
A shift in macrophage metabolism drives obesity-induced inflammation and the development of insulin resistance